Refractory Peripheral T-Cell Lymphoma
Showing 1 - 4 of 4
Refractory Peripheral T-Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma Trial in Belgium, France (Brentuximab Vedotin -
Completed
- Refractory Peripheral T-Cell Lymphoma
- Relapsed Peripheral T-Cell Lymphoma
- Brentuximab Vedotin - induction
- +3 more
-
Antwerpen, Belgium
- +38 more
Jan 9, 2023
Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Duarte, Wichita, Seattle (Folotyn and
Completed
- Relapsed Peripheral T-Cell Lymphoma
- Refractory Peripheral T-Cell Lymphoma
- Folotyn and Leucovorin
- +2 more
-
Duarte, California
- +2 more
Nov 18, 2019
Refractory Peripheral T-Cell Lymphoma, Relapsed T-Cell Lymphoma Trial in Beijing (pralatrexate, Vitamin B12 and folic acid)
Completed
- Refractory Peripheral T-Cell Lymphoma
- Relapsed T-Cell Lymphoma
- pralatrexate
- Vitamin B12 and folic acid
-
Beijing, ChinaBeijing Cancer Hospital
Sep 17, 2019
Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Worldwide (Alisertib, Pralatrexate,
Completed
- Relapsed Peripheral T-Cell Lymphoma
- Refractory Peripheral T-Cell Lymphoma
- Alisertib
- +3 more
-
Birmingham, Alabama
- +151 more
Jul 6, 2018